封面
市場調查報告書
商品編碼
1916712

益生菌和益生元市場預測至2032年:按產品、來源、劑型、通路、應用、最終用戶和地區分類的全球分析

Probiotic & Prebiotic Market Forecasts to 2032 - Global Analysis By Product (Probiotics and Prebiotics), Source, Form, Distribution Channel, Application, End User and By Geography

出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的一項研究,預計到 2025 年,全球益生菌和益生元市場價值將達到 653.4 億美元,到 2032 年將達到 1,049.2 億美元,在預測期內的複合年成長率為 7.0%。

益生菌和益生元是互補成分,共同維持健康的腸道菌叢和整體健康。益生菌是活的、有益的微生物,常見於發酵食品和膳食補充劑中,有助於平衡腸道菌叢、改善消化、增強免疫力並促進代謝健康。益生元則是不可消化的膳食纖維和化合物,它們為這些有益微生物提供營養,促進其在腸道內的生長和活性。益生菌和益生元的結合可產生協同效應,改善營養吸收、增強免疫功能、調節腸道菌叢,並有助於長期消化器官系統的平衡和健康。

人們對腸道環境的興趣日益濃厚

益生菌和益生元市場的發展主要得益於人們對腸道健康與整體健康之間聯繫的認知不斷提高。消費者越來越意識到消化平衡在免疫、代謝和心理健康方面的重要作用。這種認知,加上臨床研究和醫療建議的支持,正在推動對機能性食品、膳食補充劑和強化產品的需求。隨著人們生活方式的健康意識增強,預防保健的重要性日益凸顯,益生菌和益生元不再是小眾產品,而是成為全球市場日常營養的重要組成部分。

生產和倉儲成本高

高昂的生產和儲存成本仍是阻礙因素市場發展的主要因素。益生菌需要受控的生產環境、先進的發酵過程和嚴格的溫度控制才能維持微生物的活性。此外,低溫運輸物流和特殊包裝也會增加營運成本。這些因素推高了產品價格,並限制了成本敏感地區的市場進入。如何在確保品質的同時控制成本,一直是製造商面臨的挑戰,這可能會阻礙市場滲透。

創新和產品多元化

創新和產品多元化正在為益生菌和益生元市場創造巨大的機會。製造商正在開發新型菌株、合益素配方以及新的產品形式,例如軟糖、飲料和強化食品。個人化營養、微生物組研究和植物來源食品替代品的進步進一步擴大了市場潛力。這些創新使企業能夠瞄準不同的消費群體,包括兒童、老年人和運動員。隨著科學和消費者偏好的不斷發展,差異化產品正成為競爭激烈的全球市場中的關鍵驅動力。

監管挑戰

監管挑戰對市場構成重大威脅。各地在健康聲明、標籤和菌株核准方面的法規差異,為全球製造商帶來了許多複雜問題。嚴格的合規要求可能會延遲產品上市並增加研發成本。此外,科學檢驗標準的不一致也可能限制行銷的柔軟性。隨著監管機構加強審查以確保消費者安全,企業必須謹慎應對不斷變化的監管環境,才能在這個快速成長的市場中保持信譽並實現長期發展。

新冠疫情的影響:

新冠疫情加速了消費者對免疫力和預防保健的關注,從而對市場產生了積極影響。消費者對支持消化系統健康和免疫力維護的產品,尤其是膳食補充劑和機能性食品的需求激增。然而,供應鏈中斷和原料短缺暫時影響了生產和分銷。儘管面臨這些挑戰,疫情提高了人們的長期健康意識,從而在疫情後保持了持續的需求,並強化了益生菌和益生元在全球日常健康生活中的重要作用。

預計在預測期內,軟糖類產品將佔據最大的市場佔有率。

由於其便利性、偏好口感和易服用性,預計在預測期內,軟糖產品將佔據最大的市場佔有率。軟糖深受兒童、成人和老年消費者的喜愛,他們正在尋找膠囊和粉末的替代品。軟糖誘人的口味和形式有助於提高遵守用藥和每日攝取量。此外,製造商在不影響功效的前提下,不斷採用先進的配方技術,使益生菌和益生元軟糖成為全球市場主導且深受消費者歡迎的產品類型。

預計在預測期內,製藥業將呈現最高的複合年成長率。

由於益生菌和益生元的臨床療效不斷檢驗,並在醫療保健領域廣泛應用,預計在預測期內,醫藥領域將呈現最高的成長率。其成長主要得益於益生菌和益生元在胃腸道疾病、免疫調節和抗生素相關疾病等治療應用中的日益普及。醫療專業人員會開立藥用級製劑,因為其劑量標準化且療效已得到證實。隨著研究的深入和監管核准的增加,醫藥應用預計將快速成長,從而提升該領域在整體市場佔有率中的比例。

佔比最大的地區:

預計亞太地區將在預測期內佔據最大的市場佔有率,這主要得益於該地區人口密度高、中產階級收入不斷成長以及發酵食品在文化上被廣泛接受,這些因素將促進發酵食品的普及。健康意識的提高、膳食補充劑行業的擴張以及都市化進程的加速將進一步推動市場需求。此外,中國、日本和印度等國家機能性食品消費量的快速成長,已使亞太地區成為益生菌和益生元的主要區域市場。

複合年成長率最高的地區:

在預測期內,北美地區預計將實現最高的複合年成長率,這主要得益於其先進的醫療保健基礎設施和消費者對腸道健康的高度關注。對膳食補充劑、機能飲料和藥用級產品的強勁需求正在推動市場快速成長。持續的創新、廣泛的臨床研究以及零售和線上通路的廣泛覆蓋,都為市場的進一步擴張提供了支持。該地區對預防性醫療保健和個人化營養的重視,使北美成為益生菌和益生元市場的主要成長引擎。

關於免費客製化服務:

購買此報告的客戶可以選擇以下免費自訂選項之一:

  • 公司概況
    • 對其他市場公司(最多 3 家公司)進行全面分析
    • 主要企業SWOT分析(最多3家公司)
  • 區域細分
    • 根據客戶要求,提供主要國家的市場估算和預測以及複合年成長率(註:可行性需確認)。
  • 競爭標竿分析
    • 根據主要企業的產品系列、地理覆蓋範圍和策略聯盟進行基準分析

目錄

第1章執行摘要

第2章 前言

  • 概括
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進要素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 終端用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球益生菌和益生元市場(按產品分類)

  • 益生菌
    • 乳酸菌
    • 雙歧桿菌
    • 鏈球菌
    • 芽孢桿菌
    • 酵母菌
  • 益生元
    • 菊糖
    • 寡果醣(FOS)
    • 半乳寡糖(GOS)
    • 甘露聚醣(MOS)

6. 全球益生菌和益生元市場(依來源分類)

  • 植物來源
  • 動物源性
  • 微生物來源

7. 全球益生菌和益生元市場(按形式分類)

  • 膠囊和片劑
  • 粉末
  • 液體
  • 軟糖
  • 小袋

8. 全球益生菌和益生元市場(按分銷管道分類)

  • 超級市場和大賣場
  • 藥房和藥品商店
  • 專賣店
  • 線上零售
  • 直銷

9. 全球益生菌和益生元市場(按應用領域分類)

  • 功能性食品和飲料
    • 乳製品
    • 麵包糖果甜點
    • 非乳製品飲料
  • 營養補充品
  • 動物飼料
    • 家禽
    • 反芻動物
    • 水產養殖
  • 嬰兒奶粉
  • 製藥

10. 全球益生菌和益生元市場(按最終用戶分類)

  • 成人
  • 老年人
  • 嬰幼兒
  • 畜牧養殖戶

第11章 全球益生菌與益生元市場(按地區分類)

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 亞太其他地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第12章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第13章:企業概況

  • Nestle
  • Danone
  • Yakult Honsha
  • Ingredion Incorporated
  • Chr. Hansen
  • Roquette Freres
  • DuPont de Nemours
  • Lallemand
  • Kerry Group
  • BioGaia
  • Archer Daniels Midland Company(ADM)
  • Probi AB
  • Cargill
  • Lifeway Foods
  • BENEO GmbH
Product Code: SMRC33285

According to Stratistics MRC, the Global Probiotic & Prebiotic Market is accounted for $65.34 billion in 2025 and is expected to reach $104.92 billion by 2032 growing at a CAGR of 7.0% during the forecast period. Probiotics and prebiotics are complementary components that support a healthy gut microbiome and overall well-being. Probiotics are live beneficial microorganisms, commonly found in fermented foods and dietary supplements, that help balance intestinal bacteria, improve digestion, enhance immunity, and support metabolic health. Prebiotics, on the other hand, are non-digestible fibers and compounds that serve as nourishment for these beneficial microbes, stimulating their growth and activity in the gut. When combined, probiotics and prebiotics work synergistically to improve nutrient absorption, strengthen immune function, regulate gut health, and contribute to long-term digestive balance and wellness.

Market Dynamics:

Driver:

Growing Awareness of Gut Health

The probiotic and prebiotic market is strongly driven by growing awareness of gut health and its connection to overall wellness. Consumers increasingly recognize the role of digestive balance in immunity, metabolism, and mental health. This awareness, supported by clinical research and healthcare recommendations, has fueled demand for functional foods, supplements, and fortified products. As lifestyles become more health-conscious and preventive care gains importance, probiotics and prebiotics are no longer niche products but staples in daily nutrition routines across global markets.

Restraint:

High Production & Storage Costs

High production and storage costs remain a significant restraint for the market. Probiotics require controlled manufacturing environments, advanced fermentation processes, and strict temperature regulation to maintain microbial viability. Additionally, cold-chain logistics and specialized packaging increase operational expenses. These factors raise product prices, limiting accessibility in cost-sensitive regions. For manufacturers, maintaining quality while managing costs poses ongoing challenges, which can restrict market penetration.

Opportunity:

Innovation & Product Diversification

Innovation and product diversification present substantial opportunities for the probiotic and prebiotic market. Manufacturers are developing novel strains, synbiotic formulations, and delivery formats such as gummies, beverages, and fortified foods. Advances in personalized nutrition, microbiome research, and plant-based alternatives further expand market potential. These innovations allow companies to target diverse consumer groups, including children, seniors, and athletes. As science and consumer preferences evolve, differentiated products are becoming key growth drivers in competitive global markets.

Threat:

Regulatory Challenges

Regulatory challenges pose a notable threat to the market. Varying regulations across regions regarding health claims, labeling, and strain approval create complexities for global manufacturers. Strict compliance requirements can delay product launches and increase development costs. Additionally, inconsistent scientific validation standards may limit marketing flexibility. As authorities tighten oversight to ensure consumer safety, companies must navigate evolving regulatory landscapes carefully to sustain credibility and long-term growth in this rapidly expanding market.

Covid-19 Impact:

The COVID-19 pandemic positively influenced the market by accelerating consumer focus on immunity and preventive healthcare. Demand surged for products supporting digestive health and immune resilience, particularly supplements and functional foods. However, supply chain disruptions and raw material shortages temporarily affected production and distribution. Despite these challenges, the pandemic reinforced long-term health awareness, leading to sustained post-COVID demand and strengthening the role of probiotics and prebiotics in daily wellness routines worldwide.

The gummies segment is expected to be the largest during the forecast period

The gummies segment is expected to account for the largest market share during the forecast period, due to their convenience, palatable taste, and ease of consumption. Gummies appeal strongly to children, adults, and elderly consumers who prefer alternatives to capsules or powders. Their attractive flavors and formats improve compliance and daily intake consistency. Additionally, manufacturers are incorporating advanced formulations without compromising efficacy, making probiotic and prebiotic gummies a dominant and consumer-friendly product category in the global market.

The pharmaceuticals segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the pharmaceuticals segment is predicted to witness the highest growth rate, due to rising clinical validation and medical adoption of probiotics and prebiotics. Increasing use in therapeutic applications such as gastrointestinal disorders, immune modulation, and antibiotic-associated conditions supports growth. Healthcare professionals are prescribing pharmaceutical-grade formulations due to standardized dosages and proven efficacy. As research expands and regulatory approvals increase, pharmaceutical applications are expected to grow rapidly, strengthening this segment's contribution to overall market.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to high population density, growing middle-class income, and strong cultural acceptance of fermented foods support widespread adoption. Rising health awareness, expanding nutraceutical industries, and increasing urbanization further drives demand. Additionally, countries such as China, Japan, and India are witnessing rapid growth in functional food consumption, positioning Asia Pacific as a dominant regional market for probiotics and prebiotics.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to advanced healthcare infrastructure and high consumer awareness of gut health. Strong demand for dietary supplements, functional beverages, and pharmaceutical-grade products fuels rapid growth. Continuous innovation, extensive clinical research, and widespread availability across retail and online channels further support expansion. The region's focus on preventive healthcare and personalized nutrition makes North America a key growth engine for the probiotic and prebiotic market.

Key players in the market

Some of the key players in Probiotic & Prebiotic Market include Nestle, Danone, Yakult Honsha, Ingredion Incorporated, Chr. Hansen, Roquette Freres, DuPont de Nemours, Lallemand, Kerry Group, BioGaia, Archer Daniels Midland Company (ADM), Probi AB, Cargill, Lifeway Foods, and BENEO GmbH.

Key Developments:

In October 2025, Nestle Saudi Arabia and King Abdullah University of Science and Technology (KAUST) signed a strategic MoU this partnership blends KAUST's world-class research excellence with Nestle's global food technology know-how to promote sustainability, food safety, and healthier lifestyles, supporting Saudi Vision 2030 goals while enhancing public health, food security, and local knowledge development.

In July 2025, Nestle and IBM Research have woven old-world stewardship with cutting-edge AI, creating a generative tool that can dream up new high-barrier packaging materials-shielding products from moisture, oxygen and heat while pushing sustainability forward faster than years of lab work.

Products Covered:

  • Probiotics
  • Prebiotics

Sources Covered:

  • Plant-Based
  • Animal-Based
  • Microbial

Forms Covered:

  • Capsules & Tablets
  • Powders
  • Liquids
  • Gummies
  • Sachets

Distribution Channels Covered:

  • Supermarkets & Hypermarkets
  • Pharmacies & Drug Stores
  • Specialty Stores
  • Online Retail
  • Direct Sales

Applications Covered:

  • Functional Food & Beverages
  • Dietary Supplements
  • Animal Feed
  • Infant Formula
  • Pharmaceuticals

End Users Covered:

  • Adults
  • Geriatric Population
  • Infants & Children
  • Livestock Producers

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Probiotic & Prebiotic Market, By Product

  • 5.1 Introduction
  • 5.2 Probiotics
    • 5.2.1 Lactobacillus
    • 5.2.2 Bifidobacterium
    • 5.2.3 Streptococcus
    • 5.2.4 Bacillus
    • 5.2.5 Yeast
  • 5.3 Prebiotics
    • 5.3.1 Inulin
    • 5.3.2 Fructooligosaccharides (FOS)
    • 5.3.3 Galactooligosaccharides (GOS)
    • 5.3.4 Mannan-oligosaccharides (MOS)

6 Global Probiotic & Prebiotic Market, By Source

  • 6.1 Introduction
  • 6.2 Plant-Based
  • 6.3 Animal-Based
  • 6.4 Microbial

7 Global Probiotic & Prebiotic Market, By Form

  • 7.1 Introduction
  • 7.2 Capsules & Tablets
  • 7.3 Powders
  • 7.4 Liquids
  • 7.5 Gummies
  • 7.6 Sachets

8 Global Probiotic & Prebiotic Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Supermarkets & Hypermarkets
  • 8.3 Pharmacies & Drug Stores
  • 8.4 Specialty Stores
  • 8.5 Online Retail
  • 8.6 Direct Sales

9 Global Probiotic & Prebiotic Market, By Application

  • 9.1 Introduction
  • 9.2 Functional Food & Beverages
    • 9.2.1 Dairy Products
    • 9.2.2 Bakery & Confectionery
    • 9.2.3 Non-Dairy Beverages
  • 9.3 Dietary Supplements
  • 9.4 Animal Feed
    • 9.4.1 Poultry
    • 9.4.2 Swine
    • 9.4.3 Ruminants
    • 9.4.4 Aquaculture
  • 9.5 Infant Formula
  • 9.6 Pharmaceuticals

10 Global Probiotic & Prebiotic Market, By End User

  • 10.1 Introduction
  • 10.2 Adults
  • 10.3 Geriatric Population
  • 10.4 Infants & Children
  • 10.5 Livestock Producers

11 Global Probiotic & Prebiotic Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Nestle
  • 13.2 Danone
  • 13.3 Yakult Honsha
  • 13.4 Ingredion Incorporated
  • 13.5 Chr. Hansen
  • 13.6 Roquette Freres
  • 13.7 DuPont de Nemours
  • 13.8 Lallemand
  • 13.9 Kerry Group
  • 13.10 BioGaia
  • 13.11 Archer Daniels Midland Company (ADM)
  • 13.12 Probi AB
  • 13.13 Cargill
  • 13.14 Lifeway Foods
  • 13.15 BENEO GmbH

List of Tables

  • Table 1 Global Probiotic & Prebiotic Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Probiotic & Prebiotic Market Outlook, By Product (2024-2032) ($MN)
  • Table 3 Global Probiotic & Prebiotic Market Outlook, By Probiotics (2024-2032) ($MN)
  • Table 4 Global Probiotic & Prebiotic Market Outlook, By Lactobacillus (2024-2032) ($MN)
  • Table 5 Global Probiotic & Prebiotic Market Outlook, By Bifidobacterium (2024-2032) ($MN)
  • Table 6 Global Probiotic & Prebiotic Market Outlook, By Streptococcus (2024-2032) ($MN)
  • Table 7 Global Probiotic & Prebiotic Market Outlook, By Bacillus (2024-2032) ($MN)
  • Table 8 Global Probiotic & Prebiotic Market Outlook, By Yeast (2024-2032) ($MN)
  • Table 9 Global Probiotic & Prebiotic Market Outlook, By Prebiotics (2024-2032) ($MN)
  • Table 10 Global Probiotic & Prebiotic Market Outlook, By Inulin (2024-2032) ($MN)
  • Table 11 Global Probiotic & Prebiotic Market Outlook, By Fructooligosaccharides (FOS) (2024-2032) ($MN)
  • Table 12 Global Probiotic & Prebiotic Market Outlook, By Galactooligosaccharides (GOS) (2024-2032) ($MN)
  • Table 13 Global Probiotic & Prebiotic Market Outlook, By Mannan-oligosaccharides (MOS) (2024-2032) ($MN)
  • Table 14 Global Probiotic & Prebiotic Market Outlook, By Source (2024-2032) ($MN)
  • Table 15 Global Probiotic & Prebiotic Market Outlook, By Plant-Based (2024-2032) ($MN)
  • Table 16 Global Probiotic & Prebiotic Market Outlook, By Animal-Based (2024-2032) ($MN)
  • Table 17 Global Probiotic & Prebiotic Market Outlook, By Microbial (2024-2032) ($MN)
  • Table 18 Global Probiotic & Prebiotic Market Outlook, By Form (2024-2032) ($MN)
  • Table 19 Global Probiotic & Prebiotic Market Outlook, By Capsules & Tablets (2024-2032) ($MN)
  • Table 20 Global Probiotic & Prebiotic Market Outlook, By Powders (2024-2032) ($MN)
  • Table 21 Global Probiotic & Prebiotic Market Outlook, By Liquids (2024-2032) ($MN)
  • Table 22 Global Probiotic & Prebiotic Market Outlook, By Gummies (2024-2032) ($MN)
  • Table 23 Global Probiotic & Prebiotic Market Outlook, By Sachets (2024-2032) ($MN)
  • Table 24 Global Probiotic & Prebiotic Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 25 Global Probiotic & Prebiotic Market Outlook, By Supermarkets & Hypermarkets (2024-2032) ($MN)
  • Table 26 Global Probiotic & Prebiotic Market Outlook, By Pharmacies & Drug Stores (2024-2032) ($MN)
  • Table 27 Global Probiotic & Prebiotic Market Outlook, By Specialty Stores (2024-2032) ($MN)
  • Table 28 Global Probiotic & Prebiotic Market Outlook, By Online Retail (2024-2032) ($MN)
  • Table 29 Global Probiotic & Prebiotic Market Outlook, By Direct Sales (2024-2032) ($MN)
  • Table 30 Global Probiotic & Prebiotic Market Outlook, By Application (2024-2032) ($MN)
  • Table 31 Global Probiotic & Prebiotic Market Outlook, By Functional Food & Beverages (2024-2032) ($MN)
  • Table 32 Global Probiotic & Prebiotic Market Outlook, By Dairy Products (2024-2032) ($MN)
  • Table 33 Global Probiotic & Prebiotic Market Outlook, By Bakery & Confectionery (2024-2032) ($MN)
  • Table 34 Global Probiotic & Prebiotic Market Outlook, By Non-Dairy Beverages (2024-2032) ($MN)
  • Table 35 Global Probiotic & Prebiotic Market Outlook, By Dietary Supplements (2024-2032) ($MN)
  • Table 36 Global Probiotic & Prebiotic Market Outlook, By Animal Feed (2024-2032) ($MN)
  • Table 37 Global Probiotic & Prebiotic Market Outlook, By Poultry (2024-2032) ($MN)
  • Table 38 Global Probiotic & Prebiotic Market Outlook, By Swine (2024-2032) ($MN)
  • Table 39 Global Probiotic & Prebiotic Market Outlook, By Ruminants (2024-2032) ($MN)
  • Table 40 Global Probiotic & Prebiotic Market Outlook, By Aquaculture (2024-2032) ($MN)
  • Table 41 Global Probiotic & Prebiotic Market Outlook, By Infant Formula (2024-2032) ($MN)
  • Table 42 Global Probiotic & Prebiotic Market Outlook, By Pharmaceuticals (2024-2032) ($MN)
  • Table 43 Global Probiotic & Prebiotic Market Outlook, By End User (2024-2032) ($MN)
  • Table 44 Global Probiotic & Prebiotic Market Outlook, By Adults (2024-2032) ($MN)
  • Table 45 Global Probiotic & Prebiotic Market Outlook, By Geriatric Population (2024-2032) ($MN)
  • Table 46 Global Probiotic & Prebiotic Market Outlook, By Infants & Children (2024-2032) ($MN)
  • Table 47 Global Probiotic & Prebiotic Market Outlook, By Livestock Producers (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.